Texas 2025 - 89th Regular

Texas House Bill HB3554 Latest Draft

Bill / Introduced Version Filed 02/28/2025

Download
.pdf .doc .html
                            89R13770 MPF-D
 By: Simmons H.B. No. 3554




 A BILL TO BE ENTITLED
 AN ACT
 relating to establishment of the Texas Rare Disease Advisory
 Council.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Subtitle E, Title 2, Health and Safety Code, is
 amended by adding Chapter 101A to read as follows:
 CHAPTER 101A. TEXAS RARE DISEASE ADVISORY COUNCIL
 Sec. 101A.001.  DEFINITIONS. In this chapter:
 (1)  "Advisory council" means the Texas Rare Disease
 Advisory Council established under this chapter.
 (2)  "Rare disease" means a disease, disorder, or
 condition that affects fewer than 200,000 individuals in the United
 States.
 Sec. 101A.002.  ESTABLISHMENT. (a) The Texas Rare Disease
 Advisory Council is established to advise the governor, state
 agencies, and private entities that provide health care services or
 other treatment to individuals diagnosed with rare diseases in this
 state on strategies for improving health outcomes for those
 individuals.
 (b)  The department shall provide to the advisory council
 resources, personnel, and other administrative support as
 necessary for the council to carry out its duties under this
 chapter.
 Sec. 101A.003.  ADVISORY COUNCIL MEMBERS. (a) The advisory
 council is composed of 23 members appointed as follows:
 (1)  11 members appointed by the governor as follows:
 (A)  one representative of the department;
 (B)  one representative of the commission;
 (C)  one representative of the Texas Department of
 Insurance;
 (D)  one representative of the Texas Education
 Agency;
 (E)  one geneticist practicing in this state;
 (F)  one registered nurse or advanced practice
 registered nurse licensed and practicing in this state with
 experience in treating rare diseases;
 (G)  one hospital administrator of a hospital in
 this state that provides care to individuals diagnosed with a rare
 disease;
 (H)  one pharmacist licensed and practicing in
 this state with experience dispensing prescription drugs used in
 treating rare diseases;
 (I)  one representative of the biotechnology
 industry;
 (J)  one representative of a health insurance
 company; and
 (K)  one physician licensed and practicing in this
 state with experience in treating rare diseases;
 (2)  six members appointed by the lieutenant governor
 as follows:
 (A)  one representative of an academic research
 institution in this state that receives grant funding for rare
 disease research;
 (B)  one physician licensed and practicing in this
 state with experience in treating rare diseases;
 (C)  one individual who is 18 years of age or older
 and who is diagnosed with a rare disease;
 (D)  two individuals who are, or previously served
 as, caregivers for an individual diagnosed with a rare disease; and
 (E)  one representative of an organization that
 provides care or other support to individuals diagnosed with a rare
 disease in this state; and
 (3)  six members appointed by the speaker of the house
 of representatives as follows:
 (A)  one representative of an academic research
 institution in this state that receives grant funding for rare
 disease research;
 (B)  one physician licensed and practicing in this
 state with experience in treating rare diseases;
 (C)  one individual who is 18 years of age or older
 and who is diagnosed with a rare disease;
 (D)  two individuals who are, or previously served
 as, caregivers for an individual diagnosed with a rare disease; and
 (E)  one representative of an organization that
 provides care or other support to individuals diagnosed with a rare
 disease in this state.
 (b)  Advisory council members serve staggered four-year
 terms, with the terms of one-half of the members, or as near to
 one-half as possible, expiring February 1 of each odd-numbered
 year.
 (c)  A vacancy on the advisory council shall be filled for
 the unexpired term in the same manner as the original appointment.
 Sec. 101A.004.  PRESIDING OFFICER; ASSISTANT PRESIDING
 OFFICER. The governor shall annually select from among the
 advisory council members a presiding officer and an assistant
 presiding officer.
 Sec. 101A.005.  COUNCIL MEETINGS. (a) The advisory council
 shall meet:
 (1)  at the call of the advisory council's presiding
 officer; and
 (2)  on request by a majority of the advisory council
 members.
 (b)  A majority of the voting members of the advisory council
 constitutes a quorum.
 (c)  A meeting conducted under this section may be in person
 or by video conference call, as determined by the advisory
 council's presiding officer.
 (d)  The advisory council shall provide notice of upcoming
 advisory council meetings on the department's Internet website.
 Sec. 101A.006.  DUTIES. (a) The advisory council shall:
 (1)  consult with experts on rare diseases and solicit
 public comment to develop policy recommendations for improving the
 treatment of rare diseases in this state;
 (2)  develop strategy recommendations for academic
 research institutions of higher education in this state to
 facilitate continued research on rare diseases;
 (3)  develop strategy recommendations for health care
 providers to better recognize and diagnose rare diseases to improve
 patient treatment; and
 (4)  make recommendations to the department and other
 state agencies on matters affecting individuals diagnosed with a
 rare disease, including emergency preparedness and response
 resources for a pandemic or natural disaster.
 (b)  The advisory council shall provide the department with
 the strategy recommendations developed under Subsection (a)(3) for
 publication on the department's Internet website.
 Sec. 101A.007.  ANNUAL REPORT. (a) Not later than September
 1 of each year, the advisory council shall prepare and submit to the
 governor and commissioner a report that includes:
 (1)  a summary of the advisory council's activities for
 the preceding year; and
 (2)  recommendations for legislative or other action on
 rare disease research and care.
 (b)  The advisory council shall publish the report prepared
 and submitted under Subsection (a) on the department's Internet
 website.
 Sec. 101A.008.  APPLICABILITY OF OTHER LAW. Section
 2110.008, Government Code, does not apply to the advisory council.
 SECTION 2.  Not later than December 1, 2025, the appropriate
 appointing authority shall appoint the initial members to the Texas
 Rare Disease Advisory Council as required by Section 101A.003(a),
 Health and Safety Code, as added by this Act, with the initial
 members' terms expiring as follows:
 (1)  the terms of five members appointed under Section
 101A.003(a)(1), of three members appointed under Section
 101A.003(a)(2), and of three members appointed under Section
 101A.003(a)(3) expiring February 1, 2029; and
 (2)  the terms of six members appointed under Section
 101A.003(a)(1), of three members appointed under Section
 101A.003(a)(2), and of three members appointed under Section
 101A.003(a)(3) expiring February 1, 2031.
 SECTION 3.  Notwithstanding Section 101A.005, Health and
 Safety Code, as added by this Act, the Texas Rare Disease Advisory
 Council shall conduct the council's first meeting not later than
 January 1, 2026.
 SECTION 4.  Notwithstanding Section 101A.007, Health and
 Safety Code, as added by this Act, the Texas Rare Disease Advisory
 Council shall submit the first report required by that section not
 later than September 1, 2026.
 SECTION 5.  This Act takes effect September 1, 2025.